Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

761 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Drug interventions for the treatment of obesity in children and adolescents.
Mead E, Atkinson G, Richter B, Metzendorf MI, Baur L, Finer N, Corpeleijn E, O'Malley C, Ells LJ. Mead E, et al. Among authors: richter b. Cochrane Database Syst Rev. 2016 Nov 29;11(11):CD012436. doi: 10.1002/14651858.CD012436. Cochrane Database Syst Rev. 2016. PMID: 27899001 Free PMC article. Review.
Surgery for the treatment of obesity in children and adolescents.
Ells LJ, Mead E, Atkinson G, Corpeleijn E, Roberts K, Viner R, Baur L, Metzendorf MI, Richter B. Ells LJ, et al. Among authors: richter b. Cochrane Database Syst Rev. 2015 Jun 24;(6):CD011740. doi: 10.1002/14651858.CD011740. Cochrane Database Syst Rev. 2015. PMID: 26104326 Updated. Review.
Dipeptidyl-peptidase (DPP)-4 inhibitors and glucagon-like peptide (GLP)-1 analogues for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk for the development of type 2 diabetes mellitus.
Hemmingsen B, Sonne DP, Metzendorf MI, Richter B. Hemmingsen B, et al. Among authors: richter b. Cochrane Database Syst Rev. 2017 May 10;5(5):CD012204. doi: 10.1002/14651858.CD012204.pub2. Cochrane Database Syst Rev. 2017. PMID: 28489279 Free PMC article. Review.
Diet, physical activity or both for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus.
Hemmingsen B, Gimenez-Perez G, Mauricio D, Roqué I Figuls M, Metzendorf MI, Richter B. Hemmingsen B, et al. Among authors: richter b. Cochrane Database Syst Rev. 2017 Dec 4;12(12):CD003054. doi: 10.1002/14651858.CD003054.pub4. Cochrane Database Syst Rev. 2017. PMID: 29205264 Free PMC article. Review.
Pioglitazone for prevention or delay of type 2 diabetes mellitus and its associated complications in people at risk for the development of type 2 diabetes mellitus.
Ipsen EØ, Madsen KS, Chi Y, Pedersen-Bjergaard U, Richter B, Metzendorf MI, Hemmingsen B. Ipsen EØ, et al. Among authors: richter b. Cochrane Database Syst Rev. 2020 Nov 19;11(11):CD013516. doi: 10.1002/14651858.CD013516.pub2. Cochrane Database Syst Rev. 2020. PMID: 33210751 Free PMC article.
Sodium-glucose cotransporter (SGLT) 2 inhibitors for prevention or delay of type 2 diabetes mellitus and its associated complications in people at risk for the development of type 2 diabetes mellitus.
Hemmingsen B, Krogh J, Metzendorf MI, Richter B. Hemmingsen B, et al. Among authors: richter b. Cochrane Database Syst Rev. 2016 Apr 21;4(4):CD012106. doi: 10.1002/14651858.CD012106.pub2. Cochrane Database Syst Rev. 2016. PMID: 27101360 Free PMC article. Review.
761 results